Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

p53 isoforms Delta133p53 and p53beta are endogenous regulators of replicative cellular senescence

Kaori Fujita, Abdul M. Mondal, Izumi Horikawa, Giang H. Nguyen, Kensuke Kumamoto, Jane J. Sohn, Elise D. Bowman, Ewy A. Mathe, Aaron J. Schetter, Sharon R. Pine, Helen Ji, Borivoj Vojtesek, Jean-Christophe Bourdon, David P. Lane, Curtis C. Harris

. 2009 ; 11 (9) : 1135-1142.

Jazyk angličtina Země Anglie, Velká Británie

Perzistentní odkaz   https://www.medvik.cz/link/bmc15000037

Grantová podpora
NS9812 MZ0 CEP - Centrální evidence projektů

Digitální knihovna NLK
Plný text - Článek
Zdroj

E-zdroje Online Plný text

NLK ProQuest Central od 2000-01-01 do Před 1 rokem
Medline Complete (EBSCOhost) od 1999-05-01 do 2015-11-30
Health & Medicine (ProQuest) od 2000-01-01 do Před 1 rokem

Odkazy

PubMed 19701195
DOI 10.1038/ncb1928
Knihovny.cz E-zdroje

The finite proliferative potential of normal human cells leads to replicative cellular senescence, which is a critical barrier to tumour progression in vivo. We show that the human p53 isoforms Delta133p53 and p53beta function in an endogenous regulatory mechanism for p53-mediated replicative senescence. Induced p53beta and diminished Delta133p53 were associated with replicative senescence, but not oncogene-induced senescence, in normal human fibroblasts. The replicatively senescent fibroblasts also expressed increased levels of miR-34a, a p53-induced microRNA, the antisense inhibition of which delayed the onset of replicative senescence. The siRNA (short interfering RNA)-mediated knockdown of endogenous Delta133p53 induced cellular senescence, which was attributed to the regulation of p21(WAF1) and other p53 transcriptional target genes. In overexpression experiments, whereas p53beta cooperated with full-length p53 to accelerate cellular senescence, Delta133p53 repressed miR-34a expression and extended the cellular replicative lifespan, providing a functional connection of this microRNA to the p53 isoform-mediated regulation of senescence. The senescence-associated signature of p53 isoform expression (that is, elevated p53beta and reduced Delta133p53) was observed in vivo in colon adenomas with senescent phenotypes. The increased Delta133p53 and decreased p53beta isoform expression found in colon carcinoma may signal an escape from the senescence barrier during the progression from adenoma to carcinoma.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15000037
003      
CZ-PrNML
005      
20170424103533.0
007      
ta
008      
150106s2009 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/ncb1928 $2 doi
035    __
$a (PubMed)19701195
040    __
$a ABA008 $d ABA008 $e AACR2 $b cze
041    0_
$a eng
044    __
$a enk
100    1_
$a Fujita, Kaori $u Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
245    10
$a p53 isoforms Delta133p53 and p53beta are endogenous regulators of replicative cellular senescence / $c Kaori Fujita, Abdul M. Mondal, Izumi Horikawa, Giang H. Nguyen, Kensuke Kumamoto, Jane J. Sohn, Elise D. Bowman, Ewy A. Mathe, Aaron J. Schetter, Sharon R. Pine, Helen Ji, Borivoj Vojtesek, Jean-Christophe Bourdon, David P. Lane, Curtis C. Harris
520    9_
$a The finite proliferative potential of normal human cells leads to replicative cellular senescence, which is a critical barrier to tumour progression in vivo. We show that the human p53 isoforms Delta133p53 and p53beta function in an endogenous regulatory mechanism for p53-mediated replicative senescence. Induced p53beta and diminished Delta133p53 were associated with replicative senescence, but not oncogene-induced senescence, in normal human fibroblasts. The replicatively senescent fibroblasts also expressed increased levels of miR-34a, a p53-induced microRNA, the antisense inhibition of which delayed the onset of replicative senescence. The siRNA (short interfering RNA)-mediated knockdown of endogenous Delta133p53 induced cellular senescence, which was attributed to the regulation of p21(WAF1) and other p53 transcriptional target genes. In overexpression experiments, whereas p53beta cooperated with full-length p53 to accelerate cellular senescence, Delta133p53 repressed miR-34a expression and extended the cellular replicative lifespan, providing a functional connection of this microRNA to the p53 isoform-mediated regulation of senescence. The senescence-associated signature of p53 isoform expression (that is, elevated p53beta and reduced Delta133p53) was observed in vivo in colon adenomas with senescent phenotypes. The increased Delta133p53 and decreased p53beta isoform expression found in colon carcinoma may signal an escape from the senescence barrier during the progression from adenoma to carcinoma.
536    __
$c Grant Number: Z01 BC005480-22 (United States NCI NIH HHS)
536    __
$c Grant Number: Z01 BC005795-13 (United States NCI NIH HHS)
536    __
$c Grant Number: Z01 BC005795-14 (United States NCI NIH HHS)
536    __
$c Grant Number: Z01 BC010878-01 (United States NCI NIH HHS)
536    __
$c Grant Number: ZIA BC005795-15 (United States NCI NIH HHS)
536    __
$c Grant Number: ZIA BC010878-02 (United States NCI NIH HHS)
536    __
$c Grant Number: (United Kingdom Cancer Research UK)
590    __
$a bohemika - dle Pubmed
650    12
$a stárnutí buněk $7 D016922
650    02
$a nádorové buněčné linie $7 D045744
650    02
$a nádory tračníku $x genetika $7 D003110
650    02
$a nádory tračníku $x metabolismus $7 D003110
650    02
$a regulace genové exprese u nádorů $7 D015972
650    02
$a genový knockdown $7 D055785
650    _2
$a lidé $7 D006801
650    02
$a mikro RNA $x metabolismus $7 D035683
650    02
$a mutace $x genetika $7 D009154
650    02
$a protein - isoformy $x genetika $7 D020033
650    02
$a protein - isoformy $x metabolismus $7 D020033
650    02
$a nádorový supresorový protein p53 $x genetika $7 D016159
650    12
$a nádorový supresorový protein p53 $x metabolismus $7 D016159
700    1_
$a Mondal, Abdul M. $u Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
700    1_
$a Horikawa, Izumi $u Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
700    1_
$a Nguyen, Giang H. $u Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, USA; Howard Hughes Medical Institute - National Institutes of Health Research Scholars Program, Bethesda, MD, USA
700    1_
$a Kumamoto, Kensuke $u Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, USA
700    1_
$a Sohn, Jane J. $u Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, USA
700    1_
$a Bowman, Elise D. $u Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
700    1_
$a Mathe, Ewy A. $u Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
700    1_
$a Schetter, Aaron J. $u Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
700    1_
$a Pine, Sharon R. $u Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
700    1_
$a Ji, Helen $u Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
700    1_
$a Vojtesek, Borivoj $u Masaryk Memorial Cancer Institute, Brno, Czech Republic
700    1_
$a Bourdon, Jean-Christophe $u University of Dundee, Ninewells Hospital, Department of Surgery and Molecular Oncology, Inserm-European Associated Laboratory, Dundee, UK
700    1_
$a Lane, David P. $u University of Dundee, Ninewells Hospital, Department of Surgery and Molecular Oncology, Inserm-European Associated Laboratory, Dundee, UK; Institute of Molecular and Cell Biology, Proteos, Singapore
700    1_
$a Harris, Curtis C. $u Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
773    0_
$t Nature cell biology $x 1465-7392 $g Roč. 11, č. 9 (2009), s. 1135-1142 $w MED00005249
910    __
$a ABA008 $b B 2141 $y 4 $z 0
990    __
$a 20150106112507 $b ABA008
991    __
$a 20170424103849 $b ABA008
999    __
$a ok $b bmc $g 1057062 $s 882755
BAS    __
$a 3
BMC    __
$a 2009 $b 11 $c 9 $d 1135-1142 $i 1465-7392 $m Nature cell biology $x MED00005249
GRA    __
$a NS9812 $p MZ0
LZP    __
$a 2015-01/ab

Najít záznam

Citační ukazatele

Možnosti archivace